Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Agnosia 2Prostatic Neoplasms 1Pain, Postoperative 1Pain 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Kidney Neoplasms 1Emergencies 1Carcinoma, Renal Cell 1

Interventions

Bupivacaine 4Saline Solution 3Ketamine 3Transcutaneous Electric Nerve Stimulation 2Ropivacaine 2Radiofrequency Ablation 2Magnesium Sulfate 2Ketorolac 2Dexmedetomidine 2Control Groups 2Anesthesia, Local 2Acupuncture Therapy 2Acetaminophen 2engage 8200 1Yoga 1Varenicline 1Transdermal Patch 1Therapeutics 1Telemedicine 1Surgical Instruments 1STAMP-I protocol 1Radiosurgery 1Psilocybin 1Palliative Care 1Oxycodone 1Music Therapy 1Morphine 1Methods 1Levobupivacaine 1Ketoprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Agnosia × Ketorolac × 1 year × Clear all
NCT05597878 2026-06-01

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Terminated
58 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡